In this study, we found that methylation at the CpG4 site of the TGF-β1 promoter may affect PCOS pathogenesis and is more likely to cause insulin resistance than HA; the methylation rate is negatively correlated with fasting insulin level and HOMA-IR in the population. This evidence concerns the gene TGFB1 and polycystic ovary syndrome.